The report helps businesses gain a unique insight into the socio-economic dynamics, and helps analyze how they affect healthcare systems and their evolution. It can serve as a valuable tool with actionable guidance for sales, marketing, R&D and business managers with industry related interests.
Four chapters cover the numerical and written analysis for the following topics: Economic Outlook (38 Key industry indicators), The Healthcare System (HC system structures), Reforms (restructuring, re-engineering or austerity efforts) and the Healthcare Market (Capital Equipment, Medical Devices, Disposables and Pharmaceuticals).
The TforG report is accessible through a user friendly Business Intelligence tool. Licenses are valid for 1 year.
-In 2016, Poland recorded a GDP growth of 2.83%. Looking at its growth curve since 2011, it descended steeply from 5% in 2011, but appears to be stabilizing again; forecasted to reach 3.2% in 2018.
-Compared to other European countries, public spending in Poland is relatively low. Polish healthcare (HC) expenditures represent around 6.1% of the GDP.
-Economic growth in Poland will be driven by domestic demand (i.e. due to a growing middle class and the enhanced purchasing capacity of the population).
-Poland’s exports mainly go to Germany, the U.K., France, Czech Republic and Russia; therefore, the economy partially depends on the economic climates of these countries.
-The government, as of 2015, has been applying more stringent business regulations and increased taxation on non-Polish dominant industries. This has impacted various sectors from energy, healthcare, banking and insurance and caused a decline in investor interest, whilst increasing the number of state-owned businesses.
-Overall, Poland’s economy is expected to perform well in the next 5 years, supported by EU funding and domestic spending.
The Healthcare System:
-Polish healthcare (HC) expenditures were €25.4 bln from 2015-2016, or 6.1% of the GDP. As a percentage of GDP this expenditure is forecasted to decrease over the next 2 years, though overall expenditure will increase, due to positive forecasts of GDP growth.
-Poland’s national health fund or Narodowy Fundusz Zdrowia (NFZ) is the most important source of public funding. The state budget and lastly, the territorial self-government budgets, also collect and fund the healthcare management and provision.
-Private spending is expected to grow in the coming 3 years at a rate of 5.6%, whilst public expenditure is forecasted to grow at a lower rate of 2.2%.
-The quality of care is very widespread, with great variety possible from one public hospital to the next, or from an urban hospital in comparison to a rural facility. This creates an uncertain care map for individuals seeking effective and qualitative healthcare.
-Life expectancy is around 77.6 years old, which is below the EU average of around 83 years old. Even compared to its regional peers, Poland ranks on the lower end of the life expectancies.
-Public hospitals in Poland tend to be overcrowded and it is not uncommon to see lines of people in the hallways, waiting for treatment.
-Hospital Network implementation (2017)
-Improved access to life-saving medication (2017)
-Free pharmaceuticals for people aged 75+ (2016)
-Prescription entitlement for nurses and midwives (2016)
-Planned reform: changes in reimbursement regulation (date not confirmed)
-Objectives of the upcoming National Healthcare Plan
-The market for medical products and pharmaceuticals in Poland has increased fivefold in value over the last 12 years. Weighed down by regulatory incertitude and the limitations of the public sector’s financing, it is predicted to grow at a rate of 3.4% over the next 5 years. The private sector alone is predicted to grow at a faster rate of 5.6%.
-85% of medtech needs are imported.
-Competitive bidding processes are used for medtech procurements in public hospitals, through the use of tender notices on a public procurement bulletin issued by the Public Procurement Office.
-The private sector, being more comfortably financially and less restricted by regulations, has greater flexibility and opportunity to select suppliers.
-Compared to the popularity and rapid growth of domestic GPO use in of other EU nations in recent years, in Poland GPO procurement is quite underdeveloped.
-The relevant authority in Poland to process product applications is the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products.
-Studies have shown that much of the capital equipment in public hospitals is outdated, out of order and unsafe. There is therefore a great need for modernization in this area.
-The restructuring of the public healthcare domain has led to an increase of ambulatory/outpatient centers and short-term facilities.
-Products that reduce hospitalization time will be received warmly, considering the (public) hospital sector’s capacity shortage and financial strains.
Includes tables centralizing all relevant data on socio-demographics, macroeconomics and national Healthcare.
National Care Provision data:
Provides an overview of the Healthcare demographics: Nation Care provision data, Intensive Care units, Operating rooms, Emergency Rooms, Hospital services, Healthcare professionals.
© TforG Group – All Rights Reserved.